Cardiopulmonary bypass. Associated hemostatic abnormalities.
D000328:Adult; D000368:Aged; D001779:Blood Coagulation Factors / Q000032:analysis*; D006348:Cardiac Surgical Procedures; D002315:Cardiopulmonary Bypass / Q000009:adverse effects*; D004903:Erythrocyte Aggregation / Q000209:etiology; D005165:Factor V / Q000032:analysis; D005167:Factor VII / Q000032:analysis; D005260:Female; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis; D005340:Fibrinogen / Q000032:analysis; D005342:Fibrinolysis; D006487:Hemostasis; D006801:Humans; D008297:Male; D008875:Middle Aged; D010974:Platelet Aggregation; D011516:Prothrombin / Q000032:analysis; D011517:Prothrombin Time; D013917:Thrombin / Q000032:analysis; D013925:Thromboplastin / Q000032:analysis
D001779:Blood Coagulation Factors; D005338:Fibrin Fibrinogen Degradation Products; D005165:Factor V; D005167:Factor VII; D011516:Prothrombin; D005340:Fibrinogen; D013925:Thromboplastin; D013917:Thrombin